{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:04:54Z","timestamp":1772759094454,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.atherosclerosis.2007.04.022","type":"journal-article","created":{"date-parts":[[2007,5,31]],"date-time":"2007-05-31T14:00:56Z","timestamp":1180620056000},"page":"264-270","source":"Crossref","is-referenced-by-count":35,"title":["Elevated serum soluble endoglin (sCD105) decreased during extracorporeal elimination therapy for familial hypercholesterolemia"],"prefix":"10.1016","volume":"197","author":[{"given":"Milan","family":"Blaha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Cermanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Blaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Jarolim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ctirad","family":"Andrys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Blazek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslav","family":"Maly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Smolej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiri","family":"Zajic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Masin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Zimova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vit","family":"Rehacek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14712\/18059694.2019.1","article-title":"Extracorporeal LDL-cholesterol elimination in the treatment of severe familial hypercholesterolemia","volume":"46","author":"Bl\u00e1ha","year":"2003","journal-title":"Acta Med (Hradec Kr\u00e1lov\u00e9)"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(02)00251-4","article-title":"LDL apheresis","volume":"167","author":"Thompson","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.transci.2005.11.001","article-title":"Quo vadis, haemapheresis. Current developments in haemapheresis","volume":"34","author":"Borberg","year":"2006","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1526-0968.1999.00154.x","article-title":"Three low density lipoprotein apheresis techniques in treatment of patients with hypercholesterolemia: a long-term evaluation","volume":"3","author":"Richter","year":"1999","journal-title":"Ther Apher"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.33549\/physiolres.930460","article-title":"Selectins and monocyte chemotactic peptide as the markers of atherosclerosis activity","volume":"53","author":"Blaha","year":"2004","journal-title":"Physiol Res"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib6","first-page":"A29","article-title":"Adhesive selectin molecules, MCP-1 and endotelin-1 during long-lasting LDL apheresis in familial hyperlipoproteinemia","volume":"9","author":"Bl\u00e1ha","year":"2005","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib7","first-page":"116","article-title":"LDL-afer\u00e9za\u2014hodnocen\u00ed v\u00fdsledk\u016f 1000 proveden\u00fdch procedur. (LDL-apheresis\u2014evaluation of 1000 procedures)","volume":"11","author":"Cermanova","year":"2005","journal-title":"Transfuze a hematologie"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2007.04.022_bib8","first-page":"1","article-title":"Extracorporeal LDL-cholesterol elimination\u2014impact on the level of C-reactice protein (CRP), neopterin, endoglin and CD40 ligand (CD40L)","volume":"48","author":"Bl\u00e1ha","year":"2006","journal-title":"Cor et vasa, Supplementum"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1096\/fasebj.14.1.55","article-title":"CD105 antagonizes the inhibitory signaling of transforming growth factor beta 1 on human vascular endothelial cells","volume":"14","author":"Li","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0021-9150(95)05713-7","article-title":"Serum levels of the TGF-beta receptor are increased in atherosclerosis","volume":"120","author":"Blann","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","article-title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics","volume":"72","author":"Williams","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib12","first-page":"380","article-title":"Cholesterol and triglyceride levels and their development","volume":"136","author":"Samanek","year":"1997","journal-title":"Cas Lek Cesk"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib13","first-page":"149","article-title":"Optimization of the therapeutic procedure during LDL-apheresis\u2014computerized model","volume":"32","author":"Bl\u00e1ha","year":"2005","journal-title":"Transfus Sci"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/CIRCULATIONAHA.106.176158","article-title":"Diet and Lifestyle recommendations Revision 2006. A Scientific Statement from the American Heart Association Nutrition Committee","volume":"114","author":"Lichtenstein","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib15","doi-asserted-by":"crossref","first-page":"22765","DOI":"10.1074\/jbc.M401350200","article-title":"In the absence of type III receptor, the transforming growth factor (TGF)-\u03b2 type II-B receptor requires type I receptor to bind TGF-\u03b22","volume":"279","author":"Del Re","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib16","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1046\/j.1432-1327.2000.01621.x","article-title":"Endoglin expression on human microvascular endothelial cells","volume":"267","author":"Wong","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng1294-345","article-title":"Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type","volume":"8","author":"McAllister","year":"1994","journal-title":"Nat Gen"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib18","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.RES.84.9.1043","article-title":"Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation","volume":"84","author":"Li","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/00015559850135760","article-title":"Expression of endoglin in the transition between psoriatic uninvolved and involved skin","volume":"78","author":"Van de Kerkhof","year":"1998","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib20","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0171-9335(99)80046-6","article-title":"Endoglin overexpression modulates cellular morphology, migration, and adhesion of mouse fibroblasts","volume":"78","author":"Guerrero-Esteo","year":"1999","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib21","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1161\/01.ATV.19.10.2355","article-title":"Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries","volume":"19","author":"Erren","year":"1999","journal-title":"Arterioscler Tromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1523-1755.2002.00119.x","article-title":"Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients","volume":"61","author":"Stefoni","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00019501-200205000-00001","article-title":"Prognostic significance of plasma concentrations of transforming growth factor-beta in patients with coronary artery disease","volume":"13","author":"Tashiro","year":"2002","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib24","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/jcp.20311","article-title":"Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex","volume":"204","author":"Blanco","year":"2005","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib25","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating angiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2007.04.022_bib26","doi-asserted-by":"crossref","first-page":"27440","DOI":"10.1074\/jbc.M312561200","article-title":"Endoglin controls cell migration and composition of focal adhesions: function of the cytosolic domain","volume":"279","author":"Conley","year":"2004","journal-title":"J Biol Chem"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915007002614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915007002614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T03:16:55Z","timestamp":1683861415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915007002614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0021915007002614"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.04.022","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}